Aldara

DRUG3 trials

Sponsors

Novartis Pharmaceuticals, Genticel, University of Lausanne Hospitals

Conditions

External Genital WartsHPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSILInfluenza Vaccine

Phase 1

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

TerminatedNCT02689726

GenticelHPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL

Start: 2015-08-31End: 2016-08-31Updated: 2016-12-02

Phase 2

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

CompletedNCT02482428

Novartis PharmaceuticalsExternal Genital Warts

Start: 2015-05-12End: 2016-05-31Updated: 2021-01-05

Imiquimod and Influenza Vaccine for Immunocompromised Patients

CompletedNCT02960815

University of Lausanne HospitalsInfluenza Vaccine

Start: 2016-11-30End: 2017-06-30Updated: 2017-10-10